Clinical Trial Update: A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the safety and efficacy of IOV-3001 in adults with advanced melanoma who will receive lifileucel; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Uveal Melanoma

Drugs mentioned

• IOV-3001
• Lifileucel (autologous tumor-infiltrating lymphocytes (TIL) therapy)

Snippet

Sponsor: Iovance Biotherapeutics, Inc. | Conditions: Unresectable Melanoma, Metastatic Melanoma | Phase 1, Phase 2 | Status: RECRUITING